Views & Analysis How AI, blockchain, and big data can reduce drug development... Cutting-edge technologies are increasingly improving pharma’s R&D processes.
Views & Analysis The right formula for health Nurse plus digital plus patient equals better outcomes.
Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
Views & Analysis Graph power: life sciences lead in intelligent data use Graph technology is allowing pharma to model data in a way that offers invaluable insights for marketing, R&D and compliance teams alike.
Views & Analysis Making data science a part of the life sciences sales strate... Since the dawn of the age of ‘big data’, the life sciences industry has seen exponential growth in the amount of customer data readily available – an amount that is set to continue to grow at a
Views & Analysis Impact of data management on clinical trials: new study The correlation between the upfront time to build and release a clinical database and its impact on downstream data management.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
